Clinical Trials on Uveal Melanoma
Total 3997 results
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Completed
-
BioNTech US Inc.Apexigen, Inc.TerminatedMetastatic MelanomaUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Completed
-
Inge Marie SvaneCompleted
-
OrienGene Biotechnology Ltd.Unknown
-
A.J.M. van den EertweghCompletedCutaneous Melanoma
-
University of BaselUniversity Hospital, Basel, SwitzerlandCompletedMalignant Melanoma
-
Nantes University HospitalUMR892Completed
-
CHU de ReimsUnknown
-
CelgenePrologue Research InternationalCompleted
-
University of RegensburgUnknown
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...CompletedMetastatic MelanomaUnited States
-
Cliniques universitaires Saint-Luc- Université...TerminatedMetastatic MelanomaBelgium
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
Osaka UniversityMerck Sharp & Dohme LLC; ISHIHARA SANGYO KAISHA,LTD. JapanUnknownAdvanced MelanomaJapan
-
Skin Analytics LimitedCompleted
-
Dartmouth-Hitchcock Medical CenterTerminated
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
Duke UniversityCompletedUnresectable MelanomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Western Regional Medical CenterTerminated
-
Peking University Cancer Hospital & InstituteUnknownAdvanced MelanomaChina
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)Withdrawn
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
New England Retina AssociatesCompletedChoroidal MelanomaUnited States
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
New England Retina AssociatesGenentech, Inc.CompletedChoroidal MelanomaUnited States
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
Assistance Publique Hopitaux De MarseilleUnknownMelanoma CancerFrance
-
Hoffmann-La RocheCompleted
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
Hoag Memorial Hospital PresbyterianCompletedMetastatic MelanomaUnited States
-
Centre Oscar LambretNovartis; National Cancer Institute, FranceTerminated
-
Eisai Inc.Completed
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
Duke UniversityTerminatedMetastatic MelanomaUnited States
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
University of Massachusetts, WorcesterCompleted
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
Prof. Dr. med. Dirk SchadendorfCompletedOcular MelanomaGermany